{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:18:15Z","timestamp":1788247095901,"version":"build-2803163510"},"reference-count":0,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>The nonprofit organization Blood Cancer United acquired the remaining supply of luveltamab tazevibulin and will continue the compassionate use program for children with a rare form of AML. The move points to the challenges of funding pediatric cancer drug development.<\/jats:p>","DOI":"10.1158\/2159-8290.cd-nw2026-0077","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:11:41Z","timestamp":1783980701000},"page":"OF1-OF1","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nonprofit Acquires Abandoned Leukemia Drug Supply"],"prefix":"10.1158","volume":"16","member":"1086","published-online":{"date-parts":[[2026,7,13]]},"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/doi\/10.1158\/2159-8290.CD-NW2026-0077\/786595\/Nonprofit-Acquires-Abandoned-Leukemia-Drug","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/9\/OF1\/787669\/Nonprofit-Acquires-Abandoned-Leukemia-Drug","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/9\/OF1\/787669\/Nonprofit-Acquires-Abandoned-Leukemia-Drug","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:09:31Z","timestamp":1788246571000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/16\/9\/OF1\/787669\/Nonprofit-Acquires-Abandoned-Leukemia-Drug"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":0,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,7,13]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-nw2026-0077","relation":{},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]}}}